Introduction
Benign childhood epilepsy with centrotemporal spikes (BECTS, benign rolandic epilepsy) is the most common partial epilepsy syndrome in childhood, with male predominance. It is characterized by brief, simple, orofacial partial seizures (paresthesias and tonic or clonic activity of the lower face, often spreading to the ipsilateral arm, associated with drooling and anarthria), often occurring during sleep or upon awakening. 1, 2 Frequently, patients have additional motor and/or sensory symptoms with or without secondary generalization. The interictal EEG shows blunt highvoltage centrotemporal spikes, often followed by slow waves that are activated by sleep and tend to shift from side to side, but other brain regions may also be involved. The age at onset ranges from 1 to 14 years (peak at 7-10 years) and complete remission of seizures occurs before the age of 18 years in most patients. Patients with BECTS may, however, develop behavioural or cognitive problems, which are reversible in most of them. [3] [4] [5] [6] [7] [8] [9] Furthermore, atypical features such as status epilepticus, developmental delay, daytime-only seizures, screaming as a seizure component, and postictal Todd's paresis may occur. [10] [11] [12] [13] In some children, BECTS may evolve into epilepsy with continuous spike-waves during slow-wave sleep (CSWS)/electrical status epilepticus during slow sleep (ESES) syndrome, atypical benign focal epilepsy of childhood (ABFEC) or Landau-Kleffner syndrome, all with severe neuropsychological impairments. 2, 14, 15 A meta-analysis we performed some years ago on the clinical course of typical BECTS confirmed its favourable outcome. 16 The syndrome is strongly age-dependent: at the age of 18 years, 99.8% of the patients had entered remission, the last seizure occurring at age 13 in most patients. The mean duration of the active seizure disorder could not be calculated precisely in this meta-analysis, but was shown to be less than 3 years in most children. From the meta-analysis it seemed that a younger age at onset may be associated with a longer duration of the active disease period, and patients with multiple seizures in the first month after onset may have significantly longer active disease periods than patients who have isolated ones, but the studies analyzed did not present enough data to draw definite conclusions. Several studies have been performed afterwards observing high remission rates as well. 4, 11, 13, [17] [18] [19] [20] [21] [22] [23] Most of them, however, had a retrospective design.
We here present a prospective study, with a long follow-up duration of 12.5-17 years, in 29 children with newly diagnosed BECTS included in the Dutch Study of Epilepsy in Childhood (DSEC). We determined long-term outcome both in children with typical BECTS based on the criteria of the International League Against Epilepsy and in children with atypical BECTS on basis of seizure semiology or EEG characteristics. Aim of our study was to determine whether prognosis in children with BECTS, diagnosed shortly after onset, is indeed as good as described and whether outcome differs between children with typical BECTS and atypical BECTS. Furthermore, we compared the results from our cohort with the earlier findings from the metaanalysis and from studies performed afterwards.
Methods

Patients
The paediatric neurology departments of two university hospitals, one children's hospital and one general hospital participated in the DSEC. Between August 1, 1988 and August 1, 1992, all children aged 1 month to and including 15 years presenting with two or more newly diagnosed unprovoked seizures or a status epilepticus were enrolled in the 'Prognosis study' (n = 494 of whom 28 were excluded from analyses for several reasons). 24 Detailed inand exclusion criteria and study procedures have been presented elsewhere. [24] [25] [26] It has been estimated that the recruitment of this study was close to 75% of the expected number of children younger than 16 years with newly diagnosed epilepsy in this area and that the population was representative for the general population under the age of 16 years with epilepsy. 24 This study was approved by the medical ethical boards of all participating hospitals. All parents or caregivers gave informed consent.
Follow-up
Each child was followed with regular intervals for 5 years. After 5 years, follow-up was continued in those who were still being treated with medication or who needed medical attention. Furthermore, all children were contacted between January 2004 and January 2006 (12-17 years after enrolment) by regular mail or phone to complete a structured questionnaire about the date of their last seizure, the use of AEDs, their education, and their general health at that time-point. 27 
Syndrome classification
At enrolment, a committee of three paediatric neurologists who were involved in the study classified all epilepsies according to the classification of the epilepsies of Gastaut and Zifkin. 28 Two years after enrolment or 2 years after starting medication, all epilepsies were classified according to the 1989 classification of epilepsies and epileptic syndromes of the International League against Epilepsy. 1 For this particular study, 31 children with BECTS according to one or both classifications were selected from the original cohort of 466 children. Twenty children fulfilled the criteria of typical BECTS (clinical and EEG characteristics both typical for BECTS). Nine children were classified as having atypical BECTS. Three had atypical clinical features such as age at onset before 4 years (n = 1) or associated developmental delay or learning difficulties at inclusion (n = 2). Five children had atypical EEG abnormalities, such as frontal and temporal epileptiform abnormalities and generalized waves (n = 1), multifocal epileptiform abnormalities (n = 1), midtemporal and generalized epileptiform abnormalities (n = 1), multifocal spikes and generalized spike-wave complexes (n = 1), and generalized spike-wave complexes in one EEG and no abnormalities in other EEGs (n = 1). Of one child seizures occurred during sleep and were not witnessed, but postictal signs and EEG characteristics were compatible with BECTS.
One child was originally classified as having BECTS with typical EEG abnormalities, but with symptomatology (paleness, unresponsiveness and jerks in his arms, age at onset before 4 years) resembling clinical features of Panayiotopoulos syndrome. He was therefore excluded from the analysis. One other child had atonic seizures of 5-45 min with auditory symptoms, speech arrest and drooling, and on the EEG a subclinical status epilepticus with left centrotemporal spikes and bilateral synchronous spike-waves. Since both clinical characteristics and EEG abnormalities were atypical, this child was excluded from the analysis as well.
Statistical analyses
All analyses were performed using SPSS 16.0.1. Comparisons between the group with typical BECTS and the group with atypical BECTS were made with chi-square tests (sex, seizure type, moment of seizures, compliance, and occurrence of (secondary) generalized tonic-clonic seizures (GTCS)); t-tests (age at onset, number of seizures before enrolment, terminal remission (time from the last seizure to the moment of evaluation) after 5 years follow-up (TR 5 ), total number of seizures at 5 years, number of used AEDs, age at start AED, duration of AED use, age at stop AED, follow-up duration, terminal remission at final follow-up (TR F ), age at reaching terminal remission, and total duration of epilepsy); and MannWhitney nonparametric tests (number of failed withdrawals, number of relapses, and time between becoming seizure-free (SF) and first relapse). Nonparametric correlation analysis (Spearman) was performed between the total number of seizures and TR 5 . The number of seizures before the start of AEDs was compared between seizure types with ANOVA and t-tests.
Results
Mean age at onset of epilepsy was 8.0 years and there was slight male preponderance (Table 1) . None of the children had a positive family history for epilepsy; one child had a history of febrile seizures before the onset of BECTS. The most common seizuretypes before enrolment were GTCS and simple partial seizures. Most children (93.1%) had had less than five seizures at that time, and in the majority of children seizures occurred during sleep (Table 1) . In 26 children a CT scan was made, showing no abnormalities in any of them.
After 5 years of follow-up, all children had been seizure-free for at least 1 year (Table 1) . A significant negative correlation was observed between the total number of seizures and TR 5 (p < 0.001).
No significant differences were observed in patient characteristics or the outcome after 5 years between the 20 children with typical BECTS and the nine children with atypical BECTS (Table 1 ; some data not shown).
Antiepileptic drugs
During follow-up, 23 children (79.3%) had used antiepileptic drugs (AEDs). All but one of these children initially used carbamazepine; the other child used valproic acid. In six of the children with carbamazepine this was changed to valproic acid (n = 4) or oxcarbazepine (n = 2) because of side-effects (n = 4) or inefficacy (n = 2). Two children had had polytherapy at a certain time point. AEDs were started after a median of three seizures (range 2-12; SD 2.9). Patients who presented with generalized seizures (with or without partial seizures) were treated with AEDs after significantly less seizures (mean 3.1; range 2-6; SD 1.2) than patients who only had partial seizures (mean 6.9; range 3-12; SD 3.6) (p = 0.02). Compliance was good in 82.6%. Six children (26% of the treated patients) had one or more failures to AED withdrawal. Three children used AEDs at the end of the 5-year follow-up period; in all of them AEDs were successfully withdrawn within the next 6 months afterwards.
Children with atypical BECTS started AEDs at a significantly lower age than children with typical BECTS (Table 1) . No other significant differences were observed between the group with typical BECTS and the group with atypical BECTS in AED use, failed withdrawals or compliance (data not shown).
Final follow-up
Twenty-seven children (90%) completed the structured questionnaire after a mean follow-up duration of 14.9 years. Most patients (96.3%) had a TR F of at least 5 years and 88.9% of even more Age at start AED (years) (range; SD) 9.2 (6.0-11.9; 1.6) 7.4 (2.9-9.9; 2.5) 0. than 10 years; one patient had a TR F of half a year (Table 2) . Mean interval from first to last seizure was 2.7 years. Fig. 1 displays the age at onset, age at last seizure, and age at start and withdrawal of AEDs of the patients who were followed during the complete follow-up period. Most common age at onset was between 6 and 10 years; final remission was most frequently reached between 8 and 11 years. Two patients had a last seizure after the age of 13 years. One person had been seizure-free for 13 years when he experienced an isolated seizure at the age of 20 years (details are missing). This is the person with a TR F of half a year. One other person had three short seizures (about 8 s) in 1 day at the age of 18 years with aura during which he was 'unable to do anything' (details are missing), after being seizurefree for 7 years. Since details of the last seizure of these patients are missing, we do not know whether they were typical for BECTS. The seizures these two children experienced during the 5-year follow-up period were typical for BECTS. Fifteen children had one or more relapses after having been seizure-free for at least 6 months (Table 2) . Again, the most common seizure types were simple partial seizures and GTCS.
None of the children was using AEDs at the end of the extended follow-up. The mean duration of AED use was 3.0 years and the mean age at the time of AED withdrawal was 11.7 years.
Based on answers to questions about their education and career, it appeared that none of the children had any arrest of cognitive development during follow-up. Twelve children (44%) (had) followed (pre-)university or higher vocational education, ten (37%) intermediate vocational education. Overall, general health was good at the end of follow-up.
No significant differences in final outcome were observed between the group with typical BECTS and the group with atypical BECTS (Table 2 and data not shown).
Discussion
Our cohort of children with BECTS is representative for all children with BECTS suffering at least two seizures. Onset was between 2.5 and 11.4 years with a peak between 6 and 10 years. Most seizures occurred during sleep or on awakening. This is identical to what has been described earlier. 1, 2, 16, 29 The prognosis in our children was very good, both in children with typical BECTS and with atypical BECTS, with almost 90% being seizure-free for more than 10 years after a mean follow-up of 15 years, and a mean duration of epilepsy of 2.7 years. Many children (63%) experienced one or more GTCS. Epilepsy in none of the children evolved to Landau-Kleffner syndrome, epilepsy with CSWS or ESES syndrome, and none of the children seems to have developed learning problems.
Since our meta-analysis in 1997, several other studies on outcome of BECTS have been published (Table 3) . 4, 11, 13, [17] [18] [19] [20] [21] [22] [23] Most studies had a retrospective design and described outcome at a certain time-point instead of after a certain follow-up period. This may have caused a selection bias with e.g. exclusion of children who had BECTS at onset but had an evolution into a BECTS-related disorder with a worse prognosis. The two studies with prospective design had no fixed follow-up duration: one followed patients until 6 months after full normalization of the EEG, 4 the other had a follow-up of 'at least eight years' (actual duration of follow-up was not mentioned). 13 We used the same definition for atypical epilepsy as Datta and Sinclair. The different definitions between studies make comparisons for the atypical cases, however, difficult. Characteristics of the patients were quite similar in all studies, including ours: mean age at onset ranged from 5.5 to 8.8 years, there was slight male predominance in most studies, most seizures occurred during sleep or on awakening, total duration of active epilepsy was <1-3 years, and outcome was good with high remission rates (Table 3) . Mean age at terminal remission was around 10 years in most studies. Cognitive or learning problems developed in 0-24.6% of the children studied. The proportion of patients with (secondary) GTCS differed considerably between studies (38-94%) as well as the number of patients treated with AEDs (36-89%). The occurrence of GTCS seems not to be correlated with the prescription of AEDs (Table 3) . A possible explanation for the difference in number of treated patients may be that treatment regimens are different between countries.
Some studies tried to identify predictive factors for outcome (Table 3) . 4, 11, 13, 19, 21 None of these predictive factors (other seizure types, age at onset, multiple seizures at onset) seem to predict disease course and outcome in our cohort. There is a certain restriction to the analysis of factors indicative of a worse prognosis in a disorder that is characterized by an overall very good prognosis. Negative factors can only be explored on basis of individual variations in a cohort often without any bearing on overall statistics. Furthermore, the problem of evolution from typical BECTS to atypical BECTS or BECTS-related disorders with a worse prognosis is usually not analyzed. In contrast to findings from our meta-analysis on typical BECTS, 16 a younger age at onset was not associated with a longer duration of the active disease period, and patients with multiple seizures in the first month after onset did not have significantly longer active disease periods than patients who had isolated ones (data not shown). We realize that our cohort was quite small with 29 patients and that one or more of the described predictive factors for outcome could have been present without reaching significance levels. Furthermore, defining the occurrence of developmental or behavioural problems was not part of the original study design, making it impossible to state with certainty that these problems did indeed not occur in our cohort. Nicolai et al. described that cognitive problems were reversible in most children after becoming seizure-free. 6 Since most children in our cohort were seizurefree for more than 10 years at the end of follow-up, it is possible that if these problems had existed they had resolved at the time of last evaluation.
In conclusion, long-term outcome was good in our cohort. Except for age at the start of AEDs, no significant differences were observed between children with typical BECTS and children with atypical BECTS. No predictive factors could be identified for the course of the epilepsy. Since our cohort is representative for the whole group of children with BECTS suffering at least two seizures and has a very long follow-up period, the results warrant the prediction of a favourable prognosis in children who are diagnosed of having BECTS.
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